Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Clinical trial NCT01431053 · UNKNOWN

Trial details

NCT number: NCT01431053
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2011-07-01
Primary completion: 2014-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.